Mar 28, 2008

Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression Of Alzheimer's Disease

Stems cells derived
from umbilical cord blood are showing early potential in fighting
Alzheimer's disease, according to results from a new preclinical study
published in the March issue of Stem Cells and Development
conducted by researchers from the University of South Florida and Saneron
CCEL Therapeutics, Inc
ound that targeted immune suppression using stem
cells derived from human umbilical cord blood reduced Alzheimer's disease
progression in a mouse model
The ongoing research project has been funded in part
by Cryo-Cell International, Inc., an industry leader in stem cell
innovation and one of the nation's largest and most established family cord
blood banks. Additional study sponsors are the National Institutes of
Health's STTR grant program, Florida High Tech Corridor Matching grant
program, and the Johnnie B. Byrd, Sr. Alzheimer's Center and Research
 blog it